Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches

Lamsfus-Calle, Andres; Daniel-Moreno, Alberto; Urena-Bailen, Guillermo; Raju, Janani; Antony, Justin S.; Handgretinger, Rupert; Mezger, Markus

dc.contributor.author	Daniel Moreno, Alberto
dc.contributor.author	Raju, Janani
dc.contributor.author	Selvaraj, Justin Antony
dc.contributor.author	Handgretinger, Rupert
dc.contributor.author	Mezger, Markus
dc.contributor.author	Lamsfus Calle, Andrés
dc.contributor.author	Ureña Bailén, Guillermo
dc.date.accessioned	2020-10-06T09:48:43Z
dc.date.available	2020-10-06T09:48:43Z
dc.date.issued	2020
dc.identifier.issn	1532-1681
dc.identifier.uri	http://hdl.handle.net/10900/107556
dc.language.iso	en	de_DE
dc.publisher	Churchill Livingstone	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.blre.2019.100641	de_DE
dc.subject.ddc	610	de_DE
dc.title	Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200715072417_01305
utue.personen.roh	Lamsfus-Calle, Andres
utue.personen.roh	Daniel-Moreno, Alberto
utue.personen.roh	Urena-Bailen, Guillermo
utue.personen.roh	Raju, Janani
utue.personen.roh	Antony, Justin S.
utue.personen.roh	Handgretinger, Rupert
utue.personen.roh	Mezger, Markus
dcterms.isPartOf.ZSTitelID	Blood Reviews	de_DE
dcterms.isPartOf.ZS-Issue	Article 100641	de_DE
dcterms.isPartOf.ZS-Volume	40	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE